The study proposes to evaluate a patient navigation intervention among a sample of 446
individuals referred for CT-based lung cancer screening in an urban safety-net setting.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT02758054.
Locations matching your search criteria
United States
Texas
Dallas
UT Southwestern/Simmons Cancer Center-DallasStatus: Active
Contact: Marcella West Aguilar
Phone: 214-648-1479
Widespread implementation of CT-based lung cancer screening is underway, but its impact
on cancer morbidity and mortality can only be achieved IF people are screened at
appropriate intervals and abnormal findings are appropriately assessed. The degree to
which individuals, especially those from medically underserved populations with highest
lung cancer risks, will adhere to the complex, multi-step process of CT-based lung cancer
screening has emerged as a key question with immediate need for solution. Specific aims
of the study are as follows:
- Aim 1: Compare rates of completion for clinically recommended steps in the lung
cancer screening process between patients referred for CT-based lung cancer
screening who are randomized to the navigation intervention versus patients who
receive usual care.
- Aim 2: Compare changes in patient-reported outcomes, including satisfaction with
care, psychosocial distress, and tobacco use between patients in the navigation
intervention versus those who receive usual care for the CT-based lung cancer
screening process.
- Aim 3 (Exploratory): Explore whether differences seen in Aims 1 and 2 are moderated
theory-based patient attitudes and beliefs (perceived susceptibility, severity of
lung cancer, perceived benefits/barriers to screening, self-efficacy).
This study will offer unprecedented insight into implementation of lung cancer screening
for high-risk individuals in underserved settings. Findings will show whether navigation
interventions increase adherence to the screening process and affect patient-reported
outcomes among underserved populations. The proposed program aims to address these issues
for lung cancer screening at its inception, rather than after disparities in screening
uptake have already emerged.
Trial PhaseNo phase specified
Trial Typescreening
Lead OrganizationUT Southwestern/Simmons Cancer Center-Dallas